Junnan Ru

496 total citations
16 papers, 402 citations indexed

About

Junnan Ru is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Junnan Ru has authored 16 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Immunology and 4 papers in Cancer Research. Recurrent topics in Junnan Ru's work include Inflammasome and immune disorders (3 papers), Immune cells in cancer (3 papers) and Mesenchymal stem cell research (2 papers). Junnan Ru is often cited by papers focused on Inflammasome and immune disorders (3 papers), Immune cells in cancer (3 papers) and Mesenchymal stem cell research (2 papers). Junnan Ru collaborates with scholars based in China, Madagascar and South Korea. Junnan Ru's co-authors include Su Yang, Qichuan Zhuge, Kankai Wang, Lijie Huang, Xiao Lin, Zhongxiao Lin, Zhenzhong Wang, Jie Shen, Xiaohong Zhu and Min Wen and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Cancer Letters.

In The Last Decade

Junnan Ru

14 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Junnan Ru China	10	275	72	62	57	54	16	402
Alejandra Palomino‐Antolín Spain	11	285 1.0×	94 1.3×	81 1.3×	151 2.6×	96 1.8×	19	577
Daniel Franco United States	14	282 1.0×	25 0.3×	50 0.8×	49 0.9×	42 0.8×	24	510
Yanan Xie China	11	182 0.7×	47 0.7×	52 0.8×	23 0.4×	29 0.5×	19	393
Mee Young Choi South Korea	12	238 0.9×	42 0.6×	61 1.0×	23 0.4×	24 0.4×	16	372
Lu Xu China	12	152 0.6×	51 0.7×	23 0.4×	49 0.9×	24 0.4×	65	410
Dingyi Lv China	16	263 1.0×	31 0.4×	104 1.7×	27 0.5×	21 0.4×	29	461
Hirohide Matsuura Japan	14	159 0.6×	133 1.8×	50 0.8×	35 0.6×	39 0.7×	35	500
Ruifeng Yang China	10	317 1.2×	51 0.7×	76 1.2×	31 0.5×	22 0.4×	20	669
Yiling Cao China	11	155 0.6×	55 0.8×	62 1.0×	42 0.7×	18 0.3×	30	363

Countries citing papers authored by Junnan Ru

Since Specialization

Citations

This map shows the geographic impact of Junnan Ru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junnan Ru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junnan Ru more than expected).

Fields of papers citing papers by Junnan Ru

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junnan Ru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junnan Ru. The network helps show where Junnan Ru may publish in the future.

Co-authorship network of co-authors of Junnan Ru

This figure shows the co-authorship network connecting the top 25 collaborators of Junnan Ru. A scholar is included among the top collaborators of Junnan Ru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junnan Ru. Junnan Ru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Lin, Yuqi, Feng Li, Junnan Ru, et al.. (2025). Lower r-FEV1 as a predictor of treatment response and survival in NSCLC patients receiving neoadjuvant immunochemotherapy. Journal of Thoracic Disease. 17(8). 5816–5826.

Ru, Junnan, et al.. (2025). A deep learning approach for blood glucose monitoring and hypoglycemia prediction in glycogen storage disease. Scientific Reports. 15(1). 13032–13032.

Sun, Yujing, Xiaoyu Weng, Wei Chen, et al.. (2024). MYBBP1A‑mediated IGFBP4 promoter methylation promotes epithelial‑mesenchymal transition and metastasis through activation of NOTCH pathway in liver cancer. International Journal of Oncology. 66(1). 2 indexed citations

Ru, Junnan, Jiahua Lu, Bo Ding, et al.. (2023). IRGM is a novel regulator of PD-L1 via promoting S6K1-mediated phosphorylation of YBX1 in hepatocellular carcinoma. Cancer Letters. 581. 216495–216495. 24 indexed citations

Man, Da, Deguo Zhang, Bo Ding, et al.. (2023). ST6GALNAC4 promotes hepatocellular carcinogenesis by inducing abnormal glycosylation. Journal of Translational Medicine. 21(1). 420–420. 9 indexed citations

Ru, Junnan, Yunhao Chen, Zhenan Ling, et al.. (2023). N⁶‐methyladenosine‐modified circSTX6 promotes hepatocellular carcinoma progression by regulating the HNRNPD/ATF3 axis and encoding a 144 amino acid polypeptide. Clinical and Translational Medicine. 13(10). e1451–e1451. 25 indexed citations

Chen, Wei, Junnan Ru, Da Man, et al.. (2022). MiR-652-3p promotes malignancy and metastasis of cancer cells via inhibiting TNRC6A in hepatocellular carcinoma. Biochemical and Biophysical Research Communications. 640. 1–11. 1 indexed citations

Lin, Xiao, et al.. (2021). Pyridoxal Isonicotinoyl Hydrazone Improves Neurological Recovery by Attenuating Ferroptosis and Inflammation in Cerebral Hemorrhagic Mice. BioMed Research International. 2021(1). 9916328–9916328. 27 indexed citations

Lin, Zhongxiao, Min Wen, Xiao Lin, et al.. (2021). ANXA1 as a Prognostic and Immune Microenvironmental Marker for Gliomas Based on Transcriptomic Analysis and Experimental Validation. Frontiers in Cell and Developmental Biology. 9. 659080–659080. 12 indexed citations

10.

Zhu, Xiaohong, Lijie Huang, Ke Wu, et al.. (2021). Shikonin regulates autophagy via the AMPK/mTOR pathway and reduces apoptosis of human umbilical cord mesenchymal stem cells to improve survival in tissues surrounding brain contusion. Experimental and Therapeutic Medicine. 22(6). 1475–1475. 4 indexed citations

11.

Yang, Su, Xiaohong Zhu, Kankai Wang, et al.. (2020). VX765 Attenuates Pyroptosis and HMGB1/TLR4/NF-κB Pathways to Improve Functional Outcomes in TBI Mice. Oxidative Medicine and Cellular Longevity. 2020. 1–21. 92 indexed citations

12.

Wang, Kankai, Junnan Ru, Xiao Lin, et al.. (2020). Melatonin Enhances the Therapeutic Effect of Plasma Exosomes Against Cerebral Ischemia-Induced Pyroptosis Through the TLR4/NF-κB Pathway. Frontiers in Neuroscience. 14. 848–848. 78 indexed citations

13.

Wang, Kankai, Junnan Ru, Simin Wang, et al.. (2020). Ablation of GSDMD Improves Outcome of Ischemic Stroke Through Blocking Canonical and Non-canonical Inflammasomes Dependent Pyroptosis in Microglia. Frontiers in Neurology. 11. 577927–577927. 46 indexed citations

14.

Gu, Lei, Ke Wu, Kankai Wang, et al.. (2020). VX‐765 enhances autophagy of human umbilical cord mesenchymal stem cells against stroke‐induced apoptosis and inflammatory responses via AMPK/mTOR signaling pathway. CNS Neuroscience & Therapeutics. 26(9). 952–961. 25 indexed citations

15.

Liu, Geng, et al.. (2014). Endothelial dysfunction in patients with primary aldosteronism: a biomarker of target organ damage. Journal of Human Hypertension. 28(12). 711–715. 19 indexed citations

16.

Ru, Junnan, et al.. (2006). Re-evaluation of tacrine hepatotoxicity using gel entrapped hepatocytes. Toxicology Letters. 168(2). 140–147. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact